Medicina (Nov 2022)

Bioinformatic Analysis of the BCL-xL/BCL2L1 Interactome in Patients with Pancreatic Cancer

  • Dimitrios E. Magouliotis,
  • Anna P. Karamolegkou,
  • Prokopis-Andreas Zotos,
  • Evangelos Tatsios,
  • Athina A. Samara,
  • Dimitra Alexopoulou,
  • Fani Koutsougianni,
  • Nikos Sakellaridis,
  • Dimitris Zacharoulis,
  • Konstantinos Dimas

DOI
https://doi.org/10.3390/medicina58111663
Journal volume & issue
Vol. 58, no. 11
p. 1663

Abstract

Read online

Objectives: The aim of the present study was to analyze the differential gene expression of BCL-xL/BCL2L and the associated genetic, molecular, and biologic functions in pancreatic ductal adenocarcinoma (PDAC) by employing advanced bioinformatics to investigate potential candidate genes implicated in the pathogenesis of PDAC. Materials and Methods: Bioinformatic techniques were employed to build the gene network of BCL-xL, to assess the translational profile of BCL-xL in PDAC, assess its role in predicting PDAC, and investigate the associated biologic functions and the regulating miRNA families. Results: Microarray data extracted from one dataset was incorporated, including 130 samples (PDAC: 69; Control: 61). In addition, the expression level of BCL-xL was higher in PDAC compared to control samples (p p Conclusions: The current findings unveil the biological implications of BCL-xL in PDAC and the related molecular functions and miRNA families.

Keywords